Arbor Research Collaborative for Health

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Arbor Research Collaborative for Health sits in the top decile of US sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count).

15 total trials 5 currently recruiting 8 completed top decile by trial count

Arbor Research Collaborative for Health: 15 sponsored US clinical trials, 5 recruiting.

Arbor Research Collaborative for Health sponsors 15 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 8 completed. The most-studied condition in this pipeline is Lower Urinary Tract Symptoms, with 2 trials.

Top-decile sponsor footprint

Arbor Research Collaborative for Health ranks in the top decile of sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

What is open in the Arbor Research Collaborative for Health pipeline

5 recruiting of 15 indexed (33% open); 8 completed (53%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Lower Urinary Tract Symptoms (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Arbor Research Collaborative for Health: open-pipeline peers nationwide

Peers matched on 15 registered trials and 33% open enrollment, not the therapeutic-area sidebar.

Arbor Research Collaborative for Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05101520 0%20%40%60% Total trials Recruiting share Arbor Research Collaborative for HealthAllakosArena PharmaceuticalsArrowhead PharmaceuticalsAscentage Pharma GroupAadi BioscienceAaron CookAbivax S.A.Actuated Medical
Arbor Research Collaborative for Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Arbor Research Collaborative for Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 15 trials (± recruiting share)

Sponsors near 33% open enrollment (± trial volume)

What to do with this Arbor Research Collaborative for Health page

15 registered trials is a research-attention snapshot, not an endorsement of Arbor Research Collaborative for Health or any single study.

  • 5 of Arbor Research Collaborative for Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Lower Urinary Tract Symptoms is the condition Arbor Research Collaborative for Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Lower Urinary Tract Symptoms trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Arbor Research Collaborative for Health pipeline card: 15 registered trials from official public datasets.Report a data error.